ClinicalTrials.gg
Not yet recruitingNCT07448636Updated Mar 4, 2026

The Effect of Postpartum Mandala Coloring on Anxiety, Fatigue, Maternal Attachment and Breastfeeding Self-efficacy

An interventional study of Mandala coloring in Mandala Coloring and Postpartum, sponsored by Nuh Naci Yazgan University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-04.

Primary conditionFatigueRegistry: Anxiety DisordersReclassifiedWhy we changed it
Registry
Anxiety Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Fatigue
Why
  1. The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it.
  2. The study's title name Fatigue.
Confidence
High: the new condition is named in the study's own title. Of 46 hand-checked studies reclassified this way, 72% were exactly right and 89% in the right disease family; the registry's first term was right for 4% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Nuh Naci Yazgan University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by May 2026, 5 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 332 studies in Fatigue with a site in Turkey — 50 open to participants now, 56 under way, none of them phase 3. Fatigue · Turkey.

Planned enrollment
10th of 252
140 · median 60
Started
2026
with 41 others
No phase
249 of 332
37 open now
Primary completion
2026-05
later than 31 of 55 live
Registered
278th of 332
by date

Among the 332 studies in Fatigue with a site in Turkey, this one is the 10th largest by planned enrollment of the 252 interventional ones that give a count, is one of 42 that started in 2026, is one of 249 with no phase, reaches primary completion later than 31 of the 55 other live ones, and was the 278th registered.

Fatigue

2,231 studies on the registry are indexed under Fatigue; 427 are open to participants now.

Browse Fatigue studies →

Open to participants now

50 of the 332 studies in Fatigue with a site in Turkey are open now. Recruiting first, the newest first:

45 more — sign in →

All 50 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 239 Fatigue studies recruiting now, 111 (46%) set no upper age limit and 98 (41%) stop at 75 or younger; 23 take children under 18; 73 take healthy volunteers.

This study: 18 Years and older · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 332 studies in Fatigue with a site in Turkey, or all of them as a file.
02

Study summary

The aim of this study is to investigate the effects of mandala coloring on anxiety, fatigue, breastfeeding self-efficacy, and mother-infant bonding in postpartum mothers. The sample consists of women who have had a cesarean section at Kayseri City Hospital within the last year. Data will be collected using a Personal Information Form, the Postpartum Specific Anxiety Scale, the Short Form of the Breastfeeding Self-Efficacy Scale, the Chalder Fatigue Scale, and the Maternal Attachment Scale. Mothers meeting the inclusion criteria will be randomly assigned to intervention and control groups. Mothers in the intervention group will be informed that they will begin mandala coloring one week after their cesarean delivery. They will be asked to color a mandala twice a week for a total of 5 weeks, with each coloring session lasting 30 minutes. To eliminate the possibility of mothers forgetting to color the mandala, the researcher will send reminder messages twice a week starting from the end of the first week. The Personal Information Form will be collected through face-to-face interviews while the mothers are in the hospital. Mothers in the control group will receive routine hospital care and will not paint mandalas. Researchers will call all mothers at the end of weeks 1 and 2 to administer the Postpartum Specific Anxiety Scale and the Short Form of the Breastfeeding Self-Efficacy Scale, and at the end of weeks 4 and 6 to administer questions from the Postpartum Specific Anxiety Scale, Short Form of the Breastfeeding Self-Efficacy Scale, Chalder Fatigue Scale, and Maternal Attachment Scale, recording their responses.

Read the detailed description

The postpartum period is a time of physiological changes as well as the assumption of new roles and responsibilities. Postpartum anxiety has been relatively neglected in recent years. Defined as a condition that causes anxiety and depression of unknown origin, anxiety is seen as a normal reaction to the birth of a new baby in the postpartum period. Clinically, the prevalence of anxiety symptoms in the postpartum period ranges from 12-20%. High levels of anxiety negatively affect the bonding between mother and baby, as well as the baby's behavioral, social, and emotional development. Postpartum fatigue causes women to feel more negative and less competent than usual. Postpartum fatigue negatively impacts the mother's functional recovery, maternal behavior, infant care, relationships with family members, work performance, and self-actualization. While fatigue is common and even expected after childbirth, severe postpartum fatigue can have significant effects on women's health and activities; It has negative effects such as deterioration of maternal health, delayed return to daily life activities, early cessation of breastfeeding, and delayed infant development. Since cesarean delivery is a surgical procedure, postpartum fatigue, pain, and anxiety are higher compared to vaginal delivery. Consequently, the time to start breastfeeding is later, especially in the first 24 hours after cesarean delivery, mothers have lower breastfeeding self-efficacy, and their need for support from healthcare personnel is higher. Art therapy is reported as an effective support method that addresses the physical, mental, social, and emotional aspects of the individual and helps in coping with difficulties. Mandala, one of the art therapy methods, is defined as a method used to transfer emotions and thoughts onto paper, usually in a round shape. Studies conducted on different sample groups have found that mandala painting is effective on anxiety and fatigue. A literature review revealed that anxiety and fatigue are common in the postpartum period, negatively impacting breastfeeding self-efficacy and maternal attachment. Studies have also shown that mandala coloring is effective in reducing anxiety and fatigue. However, the effects of mandala coloring on mothers' anxiety, fatigue, breastfeeding self-efficacy, and maternal attachment in the postpartum period have not been investigated. The aim of this study is to investigate the effects of mandala coloring on anxiety, fatigue, breastfeeding self-efficacy, and maternal attachment in mothers in the postpartum period.

03

Conditions studied

  • Mandala Coloring
  • Postpartum

Browse trials for

Keywords

  • Mandala Coloring
  • postpartum
  • Anxiety
  • Fatigue
  • Maternal Attachment
  • Breastfeeding Self-Efficacy
04

In context

Fatigue Reclassified

2,231 studies on the registry are indexed under Fatigue; 427 are open to participants now.

This study's planned enrollment of 140 is above the median of 54 across 1,760 interventional studies indexed under Fatigue.

Browse Fatigue studies →

Lead sponsor

Nuh Naci Yazgan University is the lead sponsor of 19 studies on the registry; 5 are open to participants now.

Compared within Fatigue, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Anxiety Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being 18 years of age or older
  • Having had a cesarean delivery after the 37th week of gestation
  • The baby being with the mother and the mother being able to breastfeed
  • Volunteering to participate in the study
  • Having a planned cesarean section

Exclusion criteria

Exclusion Criteria:

  • The mother is currently or has previously received psychiatric treatment.
  • The mother has a physical disability in her upper extremities.
  • The mother has a vision problem.
  • The newborn has a congenital anomaly.
  • The newborn experienced an obstetric complication requiring immediate hospitalization after birth (hemorrhage, infection, bladder damage, preeclampsia, etc.).

Criteria for terminating the study:

  • The baby or mother has a medical condition requiring hospitalization within 6 weeks postpartum.
  • Communication with the mother is not possible within 6 weeks postpartum
06

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
140 participants (estimated)

Study arms

  • Experimental
    Mandala Coloring Group

    Mothers in this group will color mandalas.

    Behavioral: Mandala coloring

  • No intervention
    Control Group

    Mothers in this group will not color mandalas.

Interventions

  • BehavioralMandala coloring

    Mothers in the intervention group will be given a circular mandala template coloring book and 12 colored pencils. Mothers in the intervention group will be informed that they will start coloring mandalas one week after giving birth. They will be asked to color one mandala coloring page twice a week for a total of 5 weeks, with each coloring session lasting 30 minutes. To eliminate the possibility of mothers forgetting to color mandalas, the researcher will send reminder messages to the mothers twice a week starting from the end of the first week. Mothers will be asked to send pictures of the mandala pages they have colored to the researcher as a message.

07

What researchers measure

Primary outcomes

  1. Postpartum Specific Anxiety Scale

    The scale was developed by Fallon et al. (2016) as a 56-item scale, and was transformed into a 44-item structure through a Turkish validity and reliability study conducted by Bayri Bingöl et al. (2021). The original version of the scale was developed and validated with mothers who had infants aged 0-6 months. The scale has sub-dimensions of maternal skills and attachment, newborn well-being and safety, infant care practices, and psychosocial adjustment to motherhood. The highest possible score on the Likert-type scale is 176, and the cutoff score is 113.5. Higher scores on the scale indicate a higher incidence of anxiety symptoms. The Cronbach's alpha values for the sub-dimensions of the scale range from 0.83 to 0.90.

    Time frame: At the end of the 1st, 2nd, 4th and 6th weeks postpartum

  2. Short Form of the Breastfeeding Self-Efficacy Scale

    Developed in 1999 by Dennis and Faux to measure mothers' competence regarding breastfeeding in the postpartum period. The scale was initially developed with 33 items. In the internal consistency analysis of the scale, items with a correlation below 0.60 were removed, and the short form of the Breastfeeding Self-Efficacy Scale with 14 items was created. This scale is a 5-point Likert type. All items are scored as 1, 2, 3, 4, 5 (1=Never sure, 5=Always sure). All items in the scale have positive meanings. The lowest possible score on the scale is 14, and the highest is 70, with no cutoff point. A higher score indicates higher breastfeeding self-efficacy. The Turkish validity and reliability of the scale was established by Aluş-Tokat and Okumuş in 2010. The Cronbach's alpha coefficient of the Breastfeeding Self-Efficacy Scale is 0.86.

    Time frame: At the end of the 1st, 2nd, 4th and 6th weeks postpartum

  3. Chalder Fatigue Scale

    Developed by Cella and Chalder in 2010 for use in various populations to assess fatigue, it was adapted into Turkish by Adın et al. in 2022. The scale consists of 11 items, divided into two sub-dimensions: physical fatigue and mental fatigue, and uses a 4-point Likert scale. Scores range from 0-21 for the physical fatigue sub-dimension, 0-12 for the mental fatigue sub-dimension, and 0-33 for the total scale score. Higher scores indicate greater fatigue severity.

    Time frame: At the end of the 4th and 6th weeks postpartum

  4. Maternal Attachment Scale

    The validity and reliability study of the Turkish form of the Maternal Attachment Scale, developed by Mary E. Muller in 1994, was conducted by Kavlak and Şirin in 2009. The scale consists of 26 items on a four-point Likert scale, with higher scores indicating higher maternal attachment. The lowest possible score is 26, and the highest is 104. Cronbach's Alpha internal consistency reliability was found to be 0.77 in 1-month-old infants and 0.82 in 4-month-old infants.

    Time frame: At the end of the 4th and 6th weeks postpartum

08

Study locations

1 site
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2026; primary completion for May 2026, 2 months later.

Of 936 non-industry interventional studies with no phase under Fatigue, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's planned 2 months is below that.

Counting every sponsor, half of 989 studies reached it within 12 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 26, 2026
First posted
Mar 4, 2026
StartEst.
Mar 15, 2026
Primary completionEst.
May 20, 2026
CompletionEst.
Dec 31, 2026
Last update
Mar 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT07448636
Lead sponsor
Nuh Naci Yazgan University
Collaborators
TC Erciyes University, Kayseri City Hospital
Responsible party
DİDEM KAYA (Assistant Professor Doctor, Nuh Naci Yazgan University) — Principal investigator
First posted
Mar 4, 2026
Start date
Mar 15, 2026 (estimated)
Primary completion
May 20, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Mar 4, 2026

Study contacts

Didem Kaya, Assistant Professor Doctor
Contact
didemkaya86@gmail.com
+905343035254

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion